4051 - 4060 of 8808 Results
Title
Year
-
OPENTitle: Catechol-containing compounds are a broad class of protein aggregation inhibitors: Redox state is a key determinant of the inhibitory activitiesJournal Name: Pharmacological ResearchPublisher: Elsevier BVVol: 184Issue #:Start Page: 106409End Page: 106409Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.phrs.2022.106409Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC10074477/pdf/nihms-1882815.pdfCitation Count: 13
- Association of polygenic risk score with response to deep brain stimulation in Parkinson’s disease2023OPENTitle: Association of polygenic risk score with response to deep brain stimulation in Parkinson’s diseaseJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 23Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s12883-023-03188-5Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-023-03188-5Citation Count: 4
-
OPENTitle: Exploring the genetic and genomic connection underlying neurodegeneration with brain iron accumulation and the risk for Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 9Issue #: 1Start Page: 54End Page: 54Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41531-023-00496-yBest OA location URL: https://www.nature.com/articles/s41531-023-00496-y.pdfCitation Count: 9
-
OPENTitle: Glucocerebrosidase is imported into mitochondria and preserves complex I integrity and energy metabolismJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-023-37454-4Best OA location URL: https://pub.dzne.de/record/257563Citation Count: 52
-
OPENTitle: Feasibility and patient acceptability of a commercially available wearable and a smart phone application in identification of motor states in parkinson’s diseaseJournal Name: PLOS Digital HealthPublisher: Public Library of Science (PLoS)Vol: 2Issue #: 4Start Page: e0000225End Page: e0000225Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pdig.0000225Best OA location URL: https://journals.plos.org/digitalhealth/article/file?id=10.1371/journal.pdig.0000225&type=printableCitation Count: 5
-
OPENTitle: A six-metabolite panel as potential blood-based biomarkers for Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00239-xBest OA location URL: https://www.nature.com/articles/s41531-021-00239-x.pdfCitation Count: 43
-
OPENTitle: Salivary Lactoferrin Expression in a Mouse Model of Alzheimer’s DiseaseJournal Name: Frontiers in ImmunologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page: 749468End Page: 749468Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fimmu.2021.749468Best OA location URL: https://doi.org/10.3389/fimmu.2021.749468Citation Count: 19
-
OPENTitle: The Hsc70 disaggregation machinery removes monomer units directly from α-synuclein fibril endsJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-021-25966-wBest OA location URL: https://www.nature.com/articles/s41467-021-25966-w.pdfCitation Count: 67
-
OPENTitle: Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomesJournal Name: npj Digital MedicinePublisher: Springer Science and Business Media LLCVol: 4Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41746-021-00513-5Best OA location URL: https://www.nature.com/articles/s41746-021-00513-5.pdfCitation Count: 78
-
OPENTitle: A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline DataJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.705407Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.705407/pdfCitation Count: 67